Market Research Logo

Keloid Treatment Market: Excision Projected to be the Most Attractive Treatment Type During the Forecast Period: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)

Keloid Treatment Market: Excision Projected to be the Most Attractive Treatment Type During the Forecast Period: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)

Report introduction and structure

This Future Market Insights (FMI) report examines the global keloid treatment market for the period 2017–2027. The primary objective of the report is to offer insights into developments in the keloid treatment market that are impacting global businesses and enterprises. This report covers the global keloid treatment market performance in terms of revenue contribution from various segments. The report also includes FMI analysis of key trends, drivers, restraints and opportunities that are influencing growth of the global keloid treatment market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights.

The global keloid treatment market is segmented as follows:

Keloid treatment market, by treatment type
Keloid treatment market, by end user
Keloid treatment market, by region
The keloid treatment market report begins with an overview of keloid treatment and key market definitions. This section also underlines factors influencing revenue growth of the global keloid treatment market along with a detailing of the key trends, drivers, restraints, and opportunities. The next section of the report analyses the market based on treatment type and presents the forecast in terms of value for the next 10 years. Treatment types covered in the report include:

Occlusive Dressing
Compression Therapy
Cryosurgery
Excision
Radiation Therapy
Laser Therapy
Interferon Therapy
Intralesional Corticosteroid Injection
Others
The subsequent section covers the market analysis based on end user and presents the forecast in terms of value for the next 10 years. End users considered in the report include:

Hospitals
Dermatology Clinics
Ambulatory Surgical Centres
Others
The next section of the report highlights the growth trends of the keloid treatment market across various regions, providing a market outlook for 2017–2027 and setting the forecast within the context of the keloid treatment market. The study discusses key regional trends contributing to the growth of the keloid treatment market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.

Research methodology adopted to forecast key market numbers

We have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global keloid treatment market. An important feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective in the global market.

Competition analysis featuring top players in the global keloid treatment market

In the final section of the report, a competitive landscape is included to provide report audiences with a dashboard view, to access the key differentiators among the various competitor firms operating in the global keloid treatment market. Detailed company profiles include company-specific long-term and short-term strategies, key market offerings and recent developments in the global keloid treatment market.


1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Keloid Treatment Market View Point Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Epidemiology Analysis
3.4. Risk Factor Distribution
3.5. Recurrence Rate Analysis
3.6. Patient Population Distribution
4. North America Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Market Snapshot
4.2. Introduction
4.3. Regional Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.4.1. U.S.
4.4.2. Canada
4.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.5.1. U.S.
4.5.2. Canada
4.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
4.6.1. Occlusive Dressing
4.6.2. Compression Therapy
4.6.3. Cryosurgery
4.6.4. Excision
4.6.5. Radiation Therapy
4.6.6. Laser Therapy
4.6.7. Interferon Therapy
4.6.8. Intralesional Corticosteroid Injection
4.6.9. Others
4.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
4.7.1. Occlusive Dressing
4.7.2. Compression Therapy
4.7.3. Cryosurgery
4.7.4. Excision
4.7.5. Radiation Therapy
4.7.6. Laser Therapy
4.7.7. Interferon Therapy
4.7.8. Intralesional Corticosteroid Injection
4.7.9. Others
4.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
4.8.1. Hospitals
4.8.2. Dermatology Clinics
4.8.3. Ambulatory Surgical Centers
4.8.4. Other
4.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
4.9.1. Hospitals
4.9.2. Dermatology Clinics
4.9.3. Ambulatory Surgical Centers
4.9.4. Other
4.10. Market Attractiveness Analysis
4.10.1. By Country
4.10.2. By Treatment Type
4.10.3. By End User
5. Latin America Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Market Snapshot
5.2. Introduction
5.3. Regional Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
5.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.5.1. Brazil
5.5.2. Mexico
5.5.3. Rest of Latin America
5.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
5.6.1. Occlusive Dressing
5.6.2. Compression Therapy
5.6.3. Cryosurgery
5.6.4. Excision
5.6.5. Radiation Therapy
5.6.6. Laser Therapy
5.6.7. Interferon Therapy
5.6.8. Intralesional Corticosteroid Injection
5.6.9. Others
5.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
5.7.1. Occlusive Dressing
5.7.2. Compression Therapy
5.7.3. Cryosurgery
5.7.4. Excision
5.7.5. Radiation Therapy
5.7.6. Laser Therapy
5.7.7. Interferon Therapy
5.7.8. Intralesional Corticosteroid Injection
5.7.9. Others
5.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
5.8.1. Hospitals
5.8.2. Dermatology Clinics
5.8.3. Ambulatory Surgical Centers
5.8.4. Other
5.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
5.9.1. Hospitals
5.9.2. Dermatology Clinics
5.9.3. Ambulatory Surgical Centers
5.9.4. Other
5.10. Market Attractiveness Analysis
5.10.1. By Country
5.10.2. By Treatment Type
5.10.3. By End User
6. Western Europe Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Market Snapshot
6.2. Introduction
6.3. Regional Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Trends
6.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.4.1. Germany
6.4.2. Italy
6.4.3. France
6.4.4. Spain
6.4.5. U.K.
6.4.6. Rest of Western Europe
6.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.5.1. Germany
6.5.2. Italy
6.5.3. France
6.5.4. Spain
6.5.5. U.K.
6.5.6. Rest of Western Europe
6.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
6.6.1. Occlusive Dressing
6.6.2. Compression Therapy
6.6.3. Cryosurgery
6.6.4. Excision
6.6.5. Radiation Therapy
6.6.6. Laser Therapy
6.6.7. Interferon Therapy
6.6.8. Intralesional Corticosteroid Injection
6.6.9. Others
6.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
6.7.1. Occlusive Dressing
6.7.2. Compression Therapy
6.7.3. Cryosurgery
6.7.4. Excision
6.7.5. Radiation Therapy
6.7.6. Laser Therapy
6.7.7. Interferon Therapy
6.7.8. Intralesional Corticosteroid Injection
6.7.9. Others
6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
6.8.1. Hospitals
6.8.2. Dermatology Clinics
6.8.3. Ambulatory Surgical Centers
6.8.4. Other
6.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
6.9.1. Hospitals
6.9.2. Dermatology Clinics
6.9.3. Ambulatory Surgical Centers
6.9.4. Other
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Treatment Type
6.10.3. By End User
7. Eastern Europe Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Market Snapshot
7.2. Introduction
7.3. Regional Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Trends
7.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.5.1. Russia
7.5.2. Poland
7.5.3. Rest of Eastern Europe
7.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
7.6.1. Occlusive Dressing
7.6.2. Compression Therapy
7.6.3. Cryosurgery
7.6.4. Excision
7.6.5. Radiation Therapy
7.6.6. Laser Therapy
7.6.7. Interferon Therapy
7.6.8. Intralesional Corticosteroid Injection
7.6.9. Others
7.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
7.7.1. Occlusive Dressing
7.7.2. Compression Therapy
7.7.3. Cryosurgery
7.7.4. Excision
7.7.5. Radiation Therapy
7.7.6. Laser Therapy
7.7.7. Interferon Therapy
7.7.8. Intralesional Corticosteroid Injection
7.7.9. Others
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
7.8.1. Hospitals
7.8.2. Dermatology Clinics
7.8.3. Ambulatory Surgical Centers
7.8.4. Other
7.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
7.9.1. Hospitals
7.9.2. Dermatology Clinics
7.9.3. Ambulatory Surgical Centers
7.9.4. Other
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Treatment Type
7.10.3. By End User
8. Asia Pacific excluding Japan Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Market Snapshot
8.2. Introduction
8.3. Regional Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Trends
8.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. Rest of APEJ
8.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.5.1. China
8.5.2. India
8.5.3. Australia and New Zealand
8.5.4. Rest of APEJ
8.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
8.6.1. Occlusive Dressing
8.6.2. Compression Therapy
8.6.3. Cryosurgery
8.6.4. Excision
8.6.5. Radiation Therapy
8.6.6. Laser Therapy
8.6.7. Interferon Therapy
8.6.8. Intralesional Corticosteroid Injection
8.6.9. Others
8.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
8.7.1. Occlusive Dressing
8.7.2. Compression Therapy
8.7.3. Cryosurgery
8.7.4. Excision
8.7.5. Radiation Therapy
8.7.6. Laser Therapy
8.7.7. Interferon Therapy
8.7.8. Intralesional Corticosteroid Injection
8.7.9. Others
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
8.8.1. Hospitals
8.8.2. Dermatology Clinics
8.8.3. Ambulatory Surgical Centers
8.8.4. Other
8.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
8.9.1. Hospitals
8.9.2. Dermatology Clinics
8.9.3. Ambulatory Surgical Centers
8.9.4. Other
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Treatment Type
8.10.3. By End User
9. Japan Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Market Snapshot
9.2. Introduction
9.3. Regional Market Dynamics
9.3.1. Drivers
9.3.2. Restraints
9.3.3. Trends
9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
9.4.1. Occlusive Dressing
9.4.2. Compression Therapy
9.4.3. Cryosurgery
9.4.4. Excision
9.4.5. Radiation Therapy
9.4.6. Laser Therapy
9.4.7. Interferon Therapy
9.4.8. Intralesional Corticosteroid Injection
9.4.9. Others
9.5. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
9.5.1. Occlusive Dressing
9.5.2. Compression Therapy
9.5.3. Cryosurgery
9.5.4. Excision
9.5.5. Radiation Therapy
9.5.6. Laser Therapy
9.5.7. Interferon Therapy
9.5.8. Intralesional Corticosteroid Injection
9.5.9. Others
9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
9.6.1. Hospitals
9.6.2. Dermatology Clinics
9.6.3. Ambulatory Surgical Centers
9.6.4. Other
9.7. Market Size (US$ Mn) Forecast By End User, 2017–2027
9.7.1. Hospitals
9.7.2. Dermatology Clinics
9.7.3. Ambulatory Surgical Centers
9.7.4. Other
9.8. Market Attractiveness Analysis
9.8.1. By Treatment Type
9.8.2. By End User
10. Middle East & Africa Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Market Snapshot
10.2. Introduction
10.3. Regional Market Dynamics
10.3.1. Drivers
10.3.2. Restraints
10.3.3. Trends
10.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of MEA
10.5. Market Size (US$ Mn) Forecast By Country, 2017–2027
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
10.6. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
10.6.1. Occlusive Dressing
10.6.2. Compression Therapy
10.6.3. Cryosurgery
10.6.4. Excision
10.6.5. Radiation Therapy
10.6.6. Laser Therapy
10.6.7. Interferon Therapy
10.6.8. Intralesional Corticosteroid Injection
10.6.9. Others
10.7. Market Size (US$ Mn) and Volume Forecast By Treatment Type, 2017–2027
10.7.1. Occlusive Dressing
10.7.2. Compression Therapy
10.7.3. Cryosurgery
10.7.4. Excision
10.7.5. Radiation Therapy
10.7.6. Laser Therapy
10.7.7. Interferon Therapy
10.7.8. Intralesional Corticosteroid Injection
10.7.9. Others
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
10.8.1. Hospitals
10.8.2. Dermatology Clinics
10.8.3. Ambulatory Surgical Centers
10.8.4. Other
10.9. Market Size (US$ Mn) Forecast By End User, 2017–2027
10.9.1. Hospitals
10.9.2. Dermatology Clinics
10.9.3. Ambulatory Surgical Centers
10.9.4. Other
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Treatment Type
10.10.3. By End User
11. Competition Landscape
11.1. Competition Dashboard
11.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT)
11.2.1. Novartis AG
11.2.2. Sensus Healthcare
11.2.3. RXi Pharmaceuticals, Inc.
11.2.4. Sonoma Pharmaceuticals, Inc.
11.2.5. Perrigo Company plc.
11.2.6. Bristol-Myers Squibb Company
11.2.7. Pacific World Corporation
11.2.8. Valeant Pharmaceutical International, Inc.
11.2.9. Revitol Corporation
11.2.10. Avita Medical Limited
12. Global Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Region
12.1. Introduction/Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
12.2.1. North America
12.2.2. Latin America
12.2.3. Western Europe
12.2.4. Eastern Europe
12.2.5. Asia Pacific excluding Japan
12.2.6. Japan
12.2.7. Middle East & Africa
12.3. Market Size (US$ Mn) Forecast By Region, 2017–2027
12.3.1. North America
12.3.2. Latin America
12.3.3. Western Europe
12.3.4. Eastern Europe
12.3.5. Asia Pacific excluding Japan
12.3.6. Japan
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. Global Pain Therapeutic Solutions Market Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2012–2016
13.2.1. Occlusive Dressing
13.2.2. Compression Therapy
13.2.3. Cryosurgery
13.2.4. Excision
13.2.5. Radiation Therapy
13.2.6. Laser Therapy
13.2.7. Interferon Therapy
13.2.8. Intralesional Corticosteroid Injection
13.2.9. Others
13.3. Market Size (US$ Mn) Forecast By Treatment Type, 2017–2027
13.3.1. Occlusive Dressing
13.3.2. Compression Therapy
13.3.3. Cryosurgery
13.3.4. Excision
13.3.5. Radiation Therapy
13.3.6. Laser Therapy
13.3.7. Interferon Therapy
13.3.8. Intralesional Corticosteroid Injection
13.3.9. Others
13.4. Market Attractiveness Analysis By Treatment Type
14. Global Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By End User
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
14.2.1. Hospitals
14.2.2. Dermatology Clinics
14.2.3. Ambulatory Surgical Centers
14.2.4. Others
14.3. Market Size (US$ Mn) Forecast By End User, 2017–2027
14.3.1. Hospitals
14.3.2. Dermatology Clinics
14.3.3. Ambulatory Surgical Centers
14.3.4. Others
14.4. Market Attractiveness Analysis By End User
15. Global Keloid Treatment Market Analysis 2012–2016 and Forecast 2017–2027
15.1. Market Size and Y-o-Y Growth
15.2. Absolute $ Opportunity
16. Acronyms Used
17. Research Methodology
List of Tables
Table 01: North America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 02: North America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 03: North America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 04: Latin America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 05: Latin America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 06: Latin America Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 07: Western Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 08: Western Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 09: Western Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 10: Eastern Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 11: Eastern Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 12: Eastern Europe Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 13: APEJ Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 14: APEJ Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 15: APEJ Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 16: Japan Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 17: Japan Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Region
Table 18: MEA Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 19: MEA Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 20: MEA Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 21: Global Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Region
Table 22: Global Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By Treatment Type
Table 23: Global Keloid Treatment Market Size (US$ Mn) Trend Analysis 2012–2016 and Forecast 2017–2027, By End User

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report